MedPath

Assessment of the potential of nebulised frusemide to relieve dyspnoea in people with advanced heart failure

Phase 2
Completed
Conditions
Heart Failure
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12609000096257
Lead Sponsor
St Vincent's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
32
Inclusion Criteria

Chronic stable heart failure
New York Heart Association Class 2-3

Exclusion Criteria

Acute decompensated heart failure
NYHA Class 1 or 4
Inability to provide informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath